1122 related articles for article (PubMed ID: 18188819)
1. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
5. Does antiviral therapy prevent hepatocellular carcinoma?
Kwon H; Lok AS
Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
[TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
Pár A
Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
[TBL] [Abstract][Full Text] [Related]
7. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
8. Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.
Masuzaki R; Yoshida H; Omata M
Oncology; 2010 Jul; 78 Suppl 1():17-23. PubMed ID: 20616579
[TBL] [Abstract][Full Text] [Related]
9. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
10. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim BK; Han KH; Ahn SH
Oncology; 2011; 81 Suppl 1():41-9. PubMed ID: 22212935
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring patients with chronic hepatitis during and after therapy].
Colić-Cvrlje V; Mise S
Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
Kaczynski J
Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
[TBL] [Abstract][Full Text] [Related]
14. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
15. Prevention of hepatocellular carcinoma.
Craxì A; Cammà C
Clin Liver Dis; 2005 May; 9(2):329-46, viii. PubMed ID: 15831277
[TBL] [Abstract][Full Text] [Related]
16. Optimizing management strategies in special patient populations.
Sherman M
Am J Gastroenterol; 2006; 101 Suppl 1():S26-31. PubMed ID: 16448449
[TBL] [Abstract][Full Text] [Related]
17. Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
Vezali E; Aghemo A; Lampertico P; Colombo M
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):455-64. PubMed ID: 21435968
[TBL] [Abstract][Full Text] [Related]
18. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
Yang YF; Zhao W; Zhong YD; Xia HM; Shen L; Zhang N
J Viral Hepat; 2009 Apr; 16(4):265-71. PubMed ID: 19220736
[TBL] [Abstract][Full Text] [Related]
20. [Current status and therapeutic strategy for hepatocellular carcinoma].
Unoura M; Adachi K; Kawai H; Inagaki Y; Kaneko S; Kobayashi K
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):608-14. PubMed ID: 2157367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
